Market Cap (In CNY)
4.51 Billion
Revenue (In CNY)
2.9 Billion
Net Income (In CNY)
199.58 Million
Avg. Volume
9.78 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.94-7.08
- PE
- -
- EPS
- -
- Beta Value
- 0.258
- ISIN
- CNE000001CM5
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ren Wei
- Employee Count
- -
- Website
- https://www.yabao.com.cn
- Ipo Date
- 2002-09-26
- Details
- Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
More Stocks
-
GE
-
ALMS
-
GAMB
-
2937Gseven Co., Ltd.
2937
-
OSAGFOSRAM Licht AG
OSAGF
-
E3B
-
4374Robot Payment Inc.
4374
-
1137